Ｍ－リボミック：RIBOMIC Completes Patient Enrollment of its US Phase 2 Open-Label Extension Clinical Trial of RBM-007 for wet AMD (RAMEN Study) - 有報キャッチャー

Ｍ－リボミック（4591）　RIBOMIC Completes Patient Enrollment of its US Phase 2 Open-Label Extension Clinical Trial of RBM-007 for wet AMD (RAMEN Study) 2021/08/30

/-

読み込み中…